• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: A.I.D.D LONGFORD ARCHITECT FREE T3 REAGENT KIT; RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

A.I.D.D LONGFORD ARCHITECT FREE T3 REAGENT KIT; RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE Back to Search Results
Model Number 7K63-25
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/02/2021
Event Type  malfunction  
Manufacturer Narrative
Was this device serviced by a third party? no.All available patient information were included, no additional patient information was available.3005094123-10/22/18-001-c.Product correction letters were issued on (b)(6) 2018 to all architect total t3 (tt3) and free t3 (ft3) customers, using the i1000sr, i2000, or i2000sr instruments and who received one of the impacted lots.The letter instructed the customers to prevent this interaction by either separating the architect ft3 and/or architect tt3 assays by running these tests on different instruments from the following assays [architect tsh, architect t-uptake, architect hiv ag/ab combo, architect cortisol, architect lh, architect progrp, architect rhtlv-i/ii, architect total psa, architect afp, and architect free psa, architect 25-oh vitamin d], or by performing daily maintenance on the instrument prior to performing batch testing for all ft3 and/or tt3 samples.The mechanism of carryover involves carryover of poly-l-lysine (pll) from other assays into the conjugate dispense step in the ft3 and tt3 assays through adherence of the pipetting probe.
 
Event Description
The customer observed low or erratic results for architect free t3 while processing with the reagent lot 21081ui00.There was no reported impact to patient management.
 
Manufacturer Narrative
This follow up is submitted to populate fields d8 and/or h6 with data that had previously been provided in field h10.There is no change to the content of the data.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT FREE T3 REAGENT KIT
Type of Device
RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE
Manufacturer (Section D)
A.I.D.D LONGFORD
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
MDR Report Key11590027
MDR Text Key251202389
Report Number3005094123-2021-00056
Device Sequence Number1
Product Code CDP
UDI-Device Identifier00380740014285
UDI-Public00380740014285
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Remedial Action Notification
Type of Report Initial,Followup
Report Date 05/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/21/2021
Device Model Number7K63-25
Device Catalogue Number07K63-25
Device Lot Number21081UI00
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 03/23/2021
Initial Date FDA Received03/30/2021
Supplement Dates Manufacturer Received05/24/2021
Supplement Dates FDA Received05/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction Number3005094123-10/22/18-001
Patient Sequence Number1
Treatment
ARC I1000SR MOD, 01L86-01, (B)(4); ARC I1000SR MOD, 01L86-01, (B)(4)
-
-